as 05-30-2025 4:00pm EST
Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.
Founded: | 2016 | Country: | United States |
Employees: | N/A | City: | SALT LAKE CITY |
Market Cap: | 327.1M | IPO Year: | N/A |
Target Price: | $22.50 | AVG Volume (30 days): | 508.3K |
Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -1.02 | EPS Growth: | N/A |
52 Week Low/High: | $6.76 - $16.93 | Next Earning Date: | 05-08-2025 |
Revenue: | $827,500,000 | Revenue Growth: | -3.31% |
Revenue Growth (this year): | 1.78% | Revenue Growth (next year): | 4.50% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
SANYAL SUNNY | VREX | President and CEO | Apr 2 '25 | Sell | $11.24 | 8,749 | $98,338.76 | 190,193 | |
Honeysett Kimberley E. | VREX | SVP and CLO | Mar 20 '25 | Sell | $12.81 | 4,007 | $51,329.67 | 4,002 |
VREX Breaking Stock News: Dive into VREX Ticker-Specific Updates for Smart Investing
Simply Wall St.
14 hours ago
Insider Monkey
2 days ago
Business Wire
10 days ago
Simply Wall St.
22 days ago
GuruFocus.com
23 days ago
Zacks
23 days ago
Zacks
23 days ago
Business Wire
23 days ago
The information presented on this page, "VREX Varex Imaging Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.